Flowserve Lowers FY Sales Growth Outlook on Challenging MEAST Conditions
Flowserve lowered its fiscal-year sales growth outlook, citing more challenging operating conditions in MEAST.
Related stories
Starbucks Reports Fourth-Quarter Adjusted EPS
L impact | EARNINGS | Oct 29, 2026, 08:16 PM UTC
Coveo Solutions reports Q2 EPS of USD -0.03
Q2 EPS was USD -0.03 versus the IBES estimate of USD 0.01.
M impact | EARNINGS | Oct 29, 2026, 08:09 PM UTC
Gilead raises full-year sales outlook as HIV sales rise 18%
Gilead reported an 18% rise in quarterly HIV sales. The body begins to report quarterly adjusted EPS but provides no figure.
M impact | EARNINGS | Oct 29, 2026, 08:09 PM UTC
Dexcom Reports Q3 Adjusted EPS of $0.73 vs. $0.67 Estimate
M impact | EARNINGS | Oct 29, 2026, 08:08 PM UTC
Gilead Outlook: FY Adjusted EPS USD -1.2 to -0.85
M impact | EARNINGS | Oct 29, 2026, 08:08 PM UTC
PTC Therapeutics Sets FY Revenue Outlook
PTC Therapeutics provided a full-year revenue outlook.
M impact | EARNINGS | Oct 29, 2026, 08:08 PM UTC